The digital health pre-certification program aims to establish a streamlined approval process for digital health products. The program allows the FDA to review developers, instead of individual products, with the understanding that digital health products should be evaluated differently than traditional medical devices because software is frequently developed.
The FDA is seeking test cases from a wide range of software developers, including small and large-sized firms, companies that create various software as a medical device products as well as companies that aren’t considered to be traditional medical device manufacturers.
Companies accepted as test cases will be notified by the FDA on a rolling basis.
To access the full report, click here.
More articles on health IT:
How senators are responding to Quest Diagnostic data breach and what it means for healthcare cybersecurity
Opko Health alerts 422,600 patients of data breach
Data analytics startup wins LifeBridge Health, CareFirst’s innovation challenge